These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

397 related items for PubMed ID: 17630551

  • 21. Antiretroviral treatment change among HIV, hepatitis B virus and hepatitis C virus co-infected patients in the Australian HIV Observational Database.
    Petoumenos K, Ringland C, Australian HIV Observational Database.
    HIV Med; 2005 May; 6(3):155-63. PubMed ID: 15876281
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Hepatitis C virus infection in HIV type 1-infected individuals does not accelerate a decrease in the CD4+ cell count but does increase the likelihood of AIDS-defining events.
    Stebbing J, Waters L, Mandalia S, Bower M, Nelson M, Gazzard B.
    Clin Infect Dis; 2005 Sep 15; 41(6):906-11. PubMed ID: 16107994
    [Abstract] [Full Text] [Related]

  • 24. Hepatic steatosis in HIV-HCV coinfected patients: analysis of risk factors.
    Bani-Sadr F, Carrat F, Bedossa P, Piroth L, Cacoub P, Perronne C, Degott C, Pol S, ANRS HC02 - Ribavic Study team.
    AIDS; 2006 Feb 28; 20(4):525-31. PubMed ID: 16470116
    [Abstract] [Full Text] [Related]

  • 25. [Favorable new data for nevirapine. Antiretroviral effect confirmed--and also lipid profile].
    MMW Fortschr Med; 2004 Apr 26; 146 Spec No 1():58-60. PubMed ID: 15373051
    [No Abstract] [Full Text] [Related]

  • 26. Hepatitis B and C virus coinfection in The TREAT Asia HIV Observational Database.
    Zhou J, Dore GJ, Zhang F, Lim PL, Chen YM, TREAT Asia HIV Observational Database.
    J Gastroenterol Hepatol; 2007 Sep 26; 22(9):1510-8. PubMed ID: 17645479
    [Abstract] [Full Text] [Related]

  • 27. Analysis of severe hepatic events associated with nevirapine-containing regimens: CD4+ T-cell count and gender in hepatitis C seropositive and seronegative patients.
    Torti C, Costarelli S, De Silvestri A, Quiros-Roldan E, Lapadula G, Cologni G, Paraninfo G, Castelnuovo F, Puoti M, Carosi G, BHCC Study Group.
    Drug Saf; 2007 Sep 26; 30(12):1161-9. PubMed ID: 18035868
    [Abstract] [Full Text] [Related]

  • 28. Is the increased risk of liver enzyme elevation in patients co-infected with HIV and hepatitis virus greater in those taking antiretroviral therapy?
    Cicconi P, Cozzi-Lepri A, Phillips A, Puoti M, Antonucci G, Manconi PE, Tositti G, Colangeli V, Lichtner M, Monforte Ad, ICoNA Study Group.
    AIDS; 2007 Mar 12; 21(5):599-606. PubMed ID: 17314522
    [Abstract] [Full Text] [Related]

  • 29. Effect of highly active antiretroviral therapy on CD4 count and weight in AIDS patients seen at the UITH, Ilorin.
    Olawumi HO, Olatunji PO, Salami AK, Odeigah L, Iseniyi JO.
    Niger J Clin Pract; 2008 Dec 12; 11(4):312-5. PubMed ID: 19320401
    [Abstract] [Full Text] [Related]

  • 30. [Combined antiretroviral therapy with nevirapine of HIV-infected adults].
    Kravchenko AV.
    Ter Arkh; 2004 Dec 12; 76(11):68-71. PubMed ID: 15658542
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Switch study of nevirapine.
    AIDS Patient Care STDS; 2000 Dec 12; 14(12):672. PubMed ID: 11187109
    [No Abstract] [Full Text] [Related]

  • 33. Second-line antiretroviral therapy in resource-limited settings: the experience of Médecins Sans Frontières.
    Pujades-Rodríguez M, O'Brien D, Humblet P, Calmy A.
    AIDS; 2008 Jul 11; 22(11):1305-12. PubMed ID: 18580610
    [Abstract] [Full Text] [Related]

  • 34. Discontinuation of nevirapine because of hypersensitivity reactions in patients with prior treatment experience, compared with treatment-naive patients: the ATHENA cohort study.
    Wit FW, Kesselring AM, Gras L, Richter C, van der Ende ME, Brinkman K, Lange JM, de Wolf F, Reiss P.
    Clin Infect Dis; 2008 Mar 15; 46(6):933-40. PubMed ID: 18271750
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Hepatitis C virus seropositivity in a South African Cohort of HIV co-infected, ARV naïve patients is associated with renal insufficiency and increased mortality.
    Parboosing R, Paruk I, Lalloo UG.
    J Med Virol; 2008 Sep 15; 80(9):1530-6. PubMed ID: 18649335
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Favourable one-year ART outcomes in adult Malawians with hepatitis B and C co-infection.
    Moore E, Beadsworth MB, Chaponda M, Mhango B, Faragher B, Njala J, Hofland HW, Davies J, Hart IJ, Beeching NJ, Zijlstra EE, van Oosterhout JJ.
    J Infect; 2010 Jul 15; 61(2):155-63. PubMed ID: 20470823
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.